Latest / The Deal by S&P Global
Behind the Buyouts: Houlihan Lokey's Martin on Pharma Services Crossroads
Mark Martin, managing director and global head of pharma services and technology at Houlihan Lokey, discusses M&A momentum and investor sentiment in pharma services.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.